DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™ | Moderna, Inc.https://investors.modernatx.com/news-releases/news-release-details/darpa-awards-moderna-therapeutics-grant-25-million-develop
Moderna to take mRNA flu and HIV vaccines into Phase 1 trials this yearhttps://www.biopharma-reporter.com/Article/2021/04/15/Moderna-to-take-mRNA-flu-and-HIV-vaccines-into-Phase-1-trials-this-year